Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Biospace News
-
November 21, 2019
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Commercial
Karuna Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
Commercial
Sanofi in Talks to Sell, Spin-Off or Create Joint Venture of...
Biospace News
-
November 21, 2019
0
Commercial
Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference
Biospace News
-
November 21, 2019
0
Commercial
CODA Biotherapeutics Deepens Gene Therapy Expertise with Industry Veteran, Annahita Keravala,...
Biospace News
-
November 21, 2019
0
Commercial
Entera Bio Reports Third Quarter 2019 Financial Results and Provides Operating...
Biospace News
-
November 21, 2019
0
Commercial
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
Biospace News
-
November 21, 2019
0
1
2
3
...
322
Page 1 of 322
- Advertisement -
MOST POPULAR
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership
April 9, 2019
BioSpace Movers and Shakers: Feb. 22
February 22, 2019
Biohaven Secures Priority Review Voucher (PRV) To Expedite Regulatory Review Of...
March 18, 2019
36 Certified Great Places to Work By BioSpace Hotbed Regions
July 18, 2019
Load more
HOT NEWS
Commercial
Top Life Science Companies Hiring Now in March
Others
Salix Pharmaceuticals Marks 30-Year Anniversary With Largest Showing Of Data At...
Phase I
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase...
Commercial
RNA Therapeutics Startup Panorama Medicine Raises $3.7 Million to Accelerate Drug...
